WHY IT MATTERS: Patients and adult consumers purchasing cannabis from licensed New York dispensaries should check current recall lists and verify with their dispensary that any products they have recently purchased or plan to purchase have not been flagged for removal. CLINICAL OVERVIEW: Product recalls in regulated cannabis markets typically arise when testing laboratories identify contaminants such as pesticides, heavy metals, microbial agents, or inaccurate potency labeling that fall outside state-mandated safety thresholds. When a testing facility’s results are called into question or when products are found to be non-compliant, state regulators are obligated to pull those items from dispensary shelves to protect consumers.
Researcher: Remediated cannabis may still have harmful mold – MJBizDaily
WHY IT MATTERS: If you are using cannabis purchased from a dispensary, you should know that passing a state lab test does not guarantee your product is free from all harmful mold species, which is especially important if you have a weakened immune system or chronic lung conditions. CLINICAL OVERVIEW: Recent research highlights that cannabis products which have undergone remediation processes to address mold contamination may still harbor harmful fungal organisms that current state-mandated testing protocols fail to detect. This raises significant clinical concerns because immunocompromised patients and those with respiratory conditions may be unknowingly exposed to mycotoxins and viable mold spores, and the assumption that vaporization eliminates these contaminants appears to be unsupported by the evidence.
5 Transformative Effects of Cannabis Rescheduling: Medical Insight
In a recent landmark announcement on Cannabis Rescheduling, President Biden expressed his administration's commitment to support the rescheduling of cannabis from Schedule 1 to Schedule 3 of the Controlled Substances Act. This...